The abiraterone acetate plus prednisone and prednisone-alone groups demonstrated a significant survival difference ( P = @ ) ; surrogate distribution at @ weeks differed by treatment ( P < @ ) ; the discriminatory power of the surrogate to predict mortality was high ( weighted c-index , @ ) ; and adding the surrogate to the model eliminated the treatment effect on survival .